# Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads

> **NCT02290028** · NA · TERMINATED · sponsor: **Biotronik SE & Co. KG** · enrollment: 2226 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DEVICE:** Sentus QP left ventricular lead

## Key facts

- **NCT ID:** NCT02290028
- **Lead sponsor:** Biotronik SE & Co. KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-12-16
- **Primary completion:** 2020-01-23
- **Final completion:** 2020-01-23
- **Target enrollment:** 2226 (ACTUAL)
- **Why stopped:** BIOTRONIK received FDA approval to transition the ongoing Sentus QP Study to a new EP PASSION real-world data methodology.
- **Last updated:** 2021-03-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02290028

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02290028, "Sentus QP - Extended CRT Evaluation With Quadripolar Left Ventricular Leads". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02290028. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*